Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
作者信息
Shah P M, Stille W
机构信息
Centre of Internal Medicine/Infectious Diseases, University Hospital, Frankfurt, Germany.
出版信息
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):171-2. doi: 10.1016/0732-8893(95)00083-m.
PMID:7587035
Abstract
Third-generation cephalosporins are the drugs of choice for serious nosocomial pneumonia; however, the recommended dosages are controversial. Our study compared two of these cephalosporins and showed that 2 g cefotaxime every 12 h and 4 g ceftriaxone once daily or 2 g every 12 h proved to be effective therapies for these chest indications.
摘要
Zotero 插件